Saratov JOURNAL of Medical and Scientific Research

Vascular endothelial growth factor as a risk predictor of thromboembolic complications in patients with orthopaedic profile

Year: 2016, volume 12 Issue: №3 Pages: 354-358
Heading: Clinical Laboratory Diagnostics Article type: Original article
Authors: Vorobeva I.S., Nikitina V.V., Gladilin G.P., Ivanenko I.L.
Organization: Saratov State Medical University

Objective: to determine the risk of thromboembolic complications in orthopaedic patients. Material and methods. A survey of 151 patients who had undergone total endoprosthesis of large joints of the lower extremities, aged 25-68, under treatment in Saratov Scientific Research Institute of Orthopedics and Traumatology. Results. The performed research allowed to establish that at values of the content of VEGF-A to 183,6 PG/ml a low risk of thromboembolic complications was predicted and for values above 183,6 PG/ml high risk was prognosed. Conclusion. We have proved high efficiency of using the relationship of VEGF and PAI-1 in serum, which plays a leading role in the development of predisposition to thrombosis.

1.Guide prevention of complications in traumatology and orthopedics: application 1/632012. URL: profilaktiki-venoznyh...
2. Kremleva Y.M., Garganchuk E.N., Vorob'eva N.A. Spatial trombodinamika as a method of optimization of anticoaguiation therapy in carotid endoarterektomii. Laboratory 2014; (2): 32
3. Jain RK, Duda DG, Clark JW, Loeffler JS. Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Natl Clin Pract Oncol 2006; 3 (1): 24-40
4. Ryden L, Stendahl M, Jonsson H, et al. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up: Implication of a link between VEGF pathway and tamoxifen response. Breast Cancer Res Treat 2005; 89 (2): 135-43
5. Baranov VS, ed. The genetic passport is the basis of individual and predictive medicine. St. Petersburg: Publisher H-L, 2009; 528 p.
6. Tsiatis AC, Norris-Kirby A, Rich RG, et al. Comparison of Sanger Sequencing, Pyrosequencing, and Melting Curve Analysis for the Detection of KRAS Mutations. J Mol Diagn 2010 July; 12 (4): 425-432.

2016_03_354-358.pdf1.14 MB

No votes yet